Precisioneffect’s Lotterman Presents the Behavior Change Strat Map in MedAd News
Precisioneffect Chief Creative Officer Deborah Lotterman pens a new commentary in the latest edition of MedAd News, “Making Sense of the Irrational.” (more…)
Precision’s Schafer and Lotterman Define Financial Toxicity
Senior Vice President Jeremy Schafer and Chief Creative Officer Deborah Lotterman submit a new commentary to MedAd News,“Enriching the Patient Journey: When Cost Creates Side Effects.” (more…)
Precision’s Schafer and Gopalan Examine Consequences of Cost-Sharing Adjustment Programs in Managed Care
In the latest edition of Managed Care, Precision for Value Payer Strategy Team members Ami Gopalan and Jeremy Schafer take a look at some of the cost-sharing strategies being employed by PBMs and ask the question, What latent effects might these programs have? (more…)
Precision’s Galante Addresses 21st Century Cures Act and Future Utilization of Real-World Evidence in Clinical Leader
In the latest edition of Clinical Leader, Precision for Value’s Dominic Galante addresses how real-world evidence is being leveraged after the adoption of the 21st Century Cures Act, and provides some next steps for life science companies. (more…)
Hennessey Quoted on Adherence in MM&M
MM&M editor-in-chief Marc Iskowitz quotes Precision’s Maureen Hennessey and cites new findings from Precision for Value’s Rapid Pulse survey in an article examining Otsuka’s new “digital drug” and the continued importance of adherence. (more…)